We also found this prevalence, that Chinese patients with NSCLC had a much higher frequency of EGFR, ERBB2, and TP53 alterations but a significantly lower frequency of KRAS, BRAF, and PDGFRA alterations than the Western patient population. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.